Menarini-Stemline at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

Menarini-Stemline at SABCS 2026 in San Antonio: Booth 309.

OrganizationSABCS 2026 Attendance
Menarini-Stemline
New York, NY
Pharma
Oncology company in the Menarini Group that markets elacestrant (Orserdu) for ESR1-mutated, ER+/HER2- advanced breast cancer.
Booth
Exhibiting at Booth 309
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Menarini-Stemline

Tell us what you sell and we’ll find the people at Menarini-Stemline most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction